Indian-Origin Doctor in Britain Under Probe Over Cancer Treatment

Arackal Manu Nair was suspended from his post as consultant urologist at Solihull Hospital when colleagues voiced suspicions to the hospital administration.

A media report revealed that an Indian-origin doctor in Britain has been suspended and is facing an investigation over the treatment he gave to cancer patients.

Arackal Manu Nair was suspended from his post as consultant urologist at Solihull Hospital and "ceased working" at Spire Parkway Hospital in April 2014 when colleagues voiced suspicions to the hospital administration about his surgery, the Solihull Observer reported.

Artificial Intelligence Could Be a Powerful Tool To Improve Breast Cancer Treatment
Researchers aimed to predict how a patient would respond to two common chemotherapy medications used to treat breast cancer - paclitaxel and gemcitabine.

Nair, who since his suspension has resigned from his post at the Heart of England NHS Trust, is under investigation by the General Medical Council for his treatment of 170 radical prostatectomy patients at Solihull Hospital and his treatment of patients at the Spire Healthcare group, the daily added.

A radical prostatectomy is a common surgical procedure to remove the prostate gland where patients are diagnosed with prostate cancer.

"Following concerns regarding the clinical practice of consultant urologist Arackal Manu Nair, the trust, working with its independent sector partners Spire Parkway and BMI The Priory, requested a team from the Royal College of Surgeons to review his surgical practices in the NHS and independent sector," said Andrew Catto, executive medical director and deputy CEO at the Heart of England NHS Trust.

Potential Drug Paves the Way for Biggest Breakthrough in Throat Cancer Treatment
The medication used to treat ovarian cancer was found to stop the growth of tumors in the throat and also increased the effectiveness of chemotherapy.

The General Medical Council confirmed that Nair was under investigation for fitness to practice.

Source-IANS

3D-Printed Protein Complexes Models Could Hold the Key to Future Cancer Treatment
If the activity of one key protein, Cdc6, was blocked from joining the 'machine', the 'machine' jammed and DNA copying stopped during replication process.

New Research Raises Concerns About Early Stage Breast Cancer Treatment
The study adds to concerns that the ability to identify these lesions through mammograms may be leading to unnecessary mastectomies.